Soligenix, Inc.
SNGXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SNGX. That does not mean none is planned.
Get an email about SNGX's next catalysts
Track Soligenix (SNGX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
SNGX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.12 | FQ end Sep/2026 | Call: tbd
How SNGX's past catalysts played out
Market Overview
Stock performance and key metrics
SGX301 (synthetic hypericin)
Cutaneous T-Cell Lymphoma
Hypericin
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
SGX942
Oral Mucositis
SGX201 (delayed release beclomethasone 17,21-dipropionate)
Enteritis
Dusquetide
Behçet Disease
Mechlorethamine Topical Gel
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SGX301 (synthetic hypericin) | Phase 3 | Cutaneous T-Cell Lymphoma | - | - |
Hypericin | Phase 3 | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | - | - |
SGX942 | Phase 3 | Oral Mucositis | - | - |
SGX201 (delayed release beclomethasone 17,21-dipropionate) | Phase 2 | Enteritis | - | - |
Dusquetide | Phase 2 | Behçet Disease | - | - |
Mechlorethamine Topical Gel | Phase 2 | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | - | - |
Frequently asked questions
What is in Soligenix, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Soligenix, Inc.'s (SNGX) pipeline across Phase 3, Phase 2. Its lead program is Hypericin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Soligenix, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Soligenix, Inc. (SNGX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SNGX biotech catalysts?→
Add SNGX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Soligenix, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.